Inogen Inc - Asset Resilience Ratio
Inogen Inc (INGN) has an Asset Resilience Ratio of 5.97% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Inogen Inc (INGN) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2014–2025)
This chart shows how Inogen Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see INGN total asset value.
Liquid Assets Composition Over Time
This chart breaks down Inogen Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read Inogen Inc (INGN) financial obligations for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $17.06 Million | 5.97% |
| Total Liquid Assets | $17.06 Million | 5.97% |
Asset Resilience Insights
- Limited Liquidity: Inogen Inc maintains only 5.97% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Inogen Inc Industry Peers by Asset Resilience Ratio
Compare Inogen Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Medtronic plc
SA:MDTC34 |
Medical Devices | 7.82% |
|
Demant A/S
CO:DEMANT |
Medical Devices | -2.59% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.84% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 34.37% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
Theradiag SA
PA:ALTHE |
Medical Devices | 15.59% |
|
Biosynex
PA:ALBIO |
Medical Devices | 3.35% |
Annual Asset Resilience Ratio for Inogen Inc (2014–2025)
The table below shows the annual Asset Resilience Ratio data for Inogen Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 5.31% | $15.85 Million | $298.62 Million | -- |
| 2024-12-31 | 0.00% | $0.00 | $296.19 Million | -- |
| 2023-12-31 | 0.91% | $2.98 Million | $326.19 Million | -- |
| 2022-12-31 | 0.00% | $0.00 | $405.04 Million | -- |
| 2021-12-31 | 2.04% | $9.99 Million | $489.51 Million | -2.13pp |
| 2020-12-31 | 4.17% | $19.26 Million | $461.85 Million | +1.70pp |
| 2019-12-31 | 2.47% | $11.06 Million | $447.34 Million | -9.16pp |
| 2018-12-31 | 11.63% | $43.72 Million | $375.90 Million | +0.36pp |
| 2017-12-31 | 11.27% | $30.99 Million | $275.07 Million | +1.44pp |
| 2016-12-31 | 9.83% | $21.03 Million | $214.05 Million | -0.58pp |
| 2015-12-31 | 10.41% | $16.79 Million | $161.31 Million | -- |
| 2014-12-31 | 0.00% | $0.00 | $140.09 Million | -- |
About Inogen Inc
Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen the… Read more